CompanyGraph
China National Accord Medicines Corporation Ltd.
200028 · SZSE · China
szaccord.com.cnFinancials as of FY2025
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 7 incoming connections
- ScaleRevenue is $10.88B, above the global median of $548.88M
- FinancialsAltman Z-Score 2.47: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.90%Above 5Y avg (4.88%)
Annual Rate
HKD 0.71Paid annual
Payout Ratio
34.9%Sustainable
Payback Period
17.0 yr
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
7.34BHKD935.70M · vs all stocks (USD)
Trailing P/E
5.85xRevenue (TTM)
85.35BCNY10.88B · vs all stocks (USD)
Profit Margin
1.48%Beta
0.1030xvs all stocks
52-Week Change
-2.01%vs all stocks
Market Capitalization
7.34BHKD935.70M · vs all stocks (USD)
Enterprise Value
9.37BHKD1.19B · vs all stocks (USD)
Trailing P/E
5.85xForward P/E
3.96xPrice to Sales (TTM)
0.1007xPrice to Book (MRQ)
0.3352xEnterprise to Revenue
0.1100xEnterprise to EBITDA
4.35xGross Margin
10.12%Profit Margin
1.48%Operating Margin
2.39%Return on Assets (TTM)
2.10%Return on Equity (TTM)
4.93%Revenue (TTM)
85.35BCNY10.88B · vs all stocks (USD)
Revenue per Share (TTM)
118.92CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-0.30%Gross Profit (TTM)
8.79BCNY1.12B · vs all stocks (USD)
EBITDA (TTM)
3.47BCNY442.90M · vs all stocks (USD)
Net Income (TTM)
1.26BCNY160.65M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-5.70%Operating Cash Flow (TTM)
122.73MCNY15.64M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.48BCNY444.00M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.7059HKDUpdated Sep 20, 2026Trailing Annual Dividend Yield
5.90%vs all stocks
5-Year Average Dividend Yield
4.88%vs all stocks
Payout Ratio
34.86%Minority Interest (Equity)
3.01BCNYFY2025 · Dec 31, 2025Revenue
73.42BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
65.58BCNYFY2025 · Dec 31, 2025Gross Profit
7.84BCNYFY2025 · Dec 31, 2025Operating Income
1.85BCNY275.45M · vs all stocks (USD)
Pre-tax Income
1.51BCNYFY2025 · Dec 31, 2025Income Tax Expense
380.67MCNYFY2025 · Dec 31, 2025Net Income
1.13BCNYFY2025 · Dec 31, 2025EBIT
1.70BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.47BCNYFY2025 · Dec 31, 2025Research & Development
19.99MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.43BCNYFY2025 · Dec 31, 2025Other Operating Expenses
223.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
46.95MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
194.50MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.85CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.85CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
612.51MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
612.51MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.13BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
7.58MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-795.63MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.01BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
7.30BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.13BCNYFY2025 · Dec 31, 2025Other Non-cash Items
362.67MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.48BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-802.25MCNYFY2025 · Dec 31, 2025Capital Expenditures
-215.53MCNYFY2025 · Dec 31, 2025Net Acquisitions
-7.42MCNYFY2025 · Dec 31, 2025Purchase of Investments
-480.00KCNYFY2025 · Dec 31, 2025Sale of Investments
120.60MCNYFY2025 · Dec 31, 2025Other Investing Activity
-95.53KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-102.92MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.67BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.53BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-386.29MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.03BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.27BCNYFY2025 · Dec 31, 2025Shares Outstanding
612.22MSharesUpdated Sep 20, 2026Float Shares
261.41MSharesUpdated Sep 20, 2026% Held by Insiders
2.55%vs all stocks
% Held by Institutions
3.86%vs all stocks
Total Cash (MRQ)
6.95BCNY885.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
9.69CNYUpdated Sep 20, 2026Total Debt (MRQ)
4.18BCNY533.14M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1631xCurrent Ratio (MRQ)
1.58xBook Value per Share (MRQ)
35.77CNYUpdated Sep 20, 2026Total Assets
49.10BCNY7.33B · vs all stocks (USD)
Total Current Assets
40.20BCNYFY2025 · Dec 31, 2025Total Liabilities
27.47BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.90BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.37BCNYFY2025 · Dec 31, 2025Total Current Liabilities
26.11BCNYFY2025 · Dec 31, 2025Cash
7.30BCNYFY2025 · Dec 31, 2025Cash Equivalents
506.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
7.80BCNYFY2025 · Dec 31, 2025Accounts Receivable
21.54BCNYFY2025 · Dec 31, 2025Inventory
8.12BCNYFY2025 · Dec 31, 2025Accounts Payable
20.52BCNYFY2025 · Dec 31, 2025Short-term Debt
3.34BCNYFY2025 · Dec 31, 2025Other Current Liabilities
61.90MCNYFY2025 · Dec 31, 2025Long-term Debt
912.18MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
284.56MCNYFY2025 · Dec 31, 2025Common Stock (Book)
556.57MCNYFY2025 · Dec 31, 2025Retained Earnings
13.51BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
21.62BCNY3.23B · vs all stocks (USD)
52-Week Low
11.50HKDUpdated Sep 20, 202652-Week High
12.81HKDUpdated Sep 20, 202652-Week Change
-2.01%vs all stocks
Beta
0.1030xvs all stocks
50-Day MA
11.94HKDUpdated Sep 20, 2026200-Day MA
12.32HKDUpdated Sep 20, 2026Avg 10-Day Volume
125.13KSharesUpdated Sep 20, 2026Avg 30-Day Volume
130.56KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
2.05CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 160,650,479.623Operating Cash Flow (USD, TTM): 15,644,169.008
Financial Health
Altman Z-Score 2.47: grey zoneSignificant
Altman Z-Score: 2.47
Supply Chain
Midstream position: 6 outgoing, 7 incoming connectionsNotable
Outgoing: 6.00Incoming: 7.00
High connectivity hub: 13 industry connectionsNotable
Total Connections: 13.00
Scale
Revenue is $10.88B, above the global median of $548.88MNotable
Revenue (USD): 10,879,815,935.85Global Median: 548,883,780.48
Levered free cash flow is $444M, above the global median of $18.73MNotable
Levered free cash flow (USD): 444,000,884.237Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Safe Bulkers Inc.
Tier 1FlowThroughput-Bound ConversionProductionRisk
CTT - Correios de Portugal, S.A.
Tier 1FlowThroughput-Bound ConversionInterfaceRisk
Beijing Oriental Jicheng Co., Ltd.
Tier 1FlowThroughput-Bound ConversionRiskInterface
SBS Holdings, Inc.
Tier 1FlowThroughput-Bound ConversionInterfaceRisk
Guangxi Liyao Group Co. Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
SG Mart Limited
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
Cargojet Inc.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Hidrovias do Brasil S.A.
Tier 1FlowThroughput-Bound ConversionProductionRisk
China High-Speed Railway Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Arjo AB (publ)
Tier 1FlowThroughput-Bound ConversionProductionRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Fischer Medical Ventures Ltd
1 interpretationReceivables Heavy and Growing
Cecep Environmental Protection Co. Ltd.
1 interpretationReceivables Heavy and Growing
Shanghai Yanpu Metal Products Co. Ltd.
1 interpretationReceivables Heavy and Growing